Prospective multi-center study of the impact of Oncotype® DX Colon Cancer Assay results on treatment recommendations in stage II colon cancer patients

被引：0
|
作者：
Srivastava, G. [1 ]
Renfro, L. A. [1 ]
Behrens, R. J. [2 ]
Lopatin, M. [3 ]
Chao, C. [3 ]
Soori, G. S. [4 ]
Dakhil, S. R. [5 ]
Kim, G. [6 ]
Lee, M. [3 ]
Alberts, S. R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Med Oncol & Hematol Associates, Oncol, Des Moines, IA USA
[3] Genom Hlth Inc, Red Wood City, CA USA
[4] Alegent Bergen Mercy Canc Ctr, Omaha, NE USA
[5] Canc Ctr Kansas, Wichita, KS USA
[6] Mayo Clin, Jacksonville, FL 32224 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2184
引用
收藏
页码：S493 / S493
页数：1
相关论文
共 50 条
  • [41] Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
    Ueno, Hideki
    Ishiguro, Megumi
    Nakatani, Eiji
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    Matsuda, Chu
    Nakamoto, Yoshihiko
    Kotake, Masanori
    Kurachi, Kiyotaka
    Egawa, Tomohisa
    Yasumasa, Keigo
    Murata, Kohei
    Ikawa, Osamu
    Shinji, Seiichi
    Murotani, Kenta
    Matsui, Shigeyuki
    Teramukai, Satoshi
    Tomita, Naohiro
    Sugihara, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (22) : 1886 - +
  • [42] Quality improvement measures and focused pathological staging without adjuvant chemotherapy in stage II colon cancer: interim results from a National Cancer Institute sponsored international prospective multi-center trial
    Bilchik, Anton J.
    Protic, Mladjan
    Nissan, Aviram
    Wainberg, Zev
    Steele, Scott R.
    Avital, Itzhak
    Stojadinovic, Alexander
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E45 - E45
  • [43] Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
    Kexuan Li
    Fuqiang Zhao
    Yuchen Guo
    Qingbin Wu
    Shuangling Luo
    Junling Zhang
    Heli Li
    Shidong Hu
    Bin Wu
    Guole Lin
    Huizhong Qiu
    Beizhan Niu
    Xiyu Sun
    Lai Xu
    Junyang Lu
    Xiaohui Du
    Zheng Wang
    Xin Wang
    Liang Kang
    Ziqiang Wang
    Quan Wang
    Qian Liu
    Yi Xiao
    BMC Cancer, 23 (1)
  • [44] A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer
    Rangaswamy Govindarajan
    James Posey
    Calvin Y. Chao
    Ruixiao Lu
    Trafina Jadhav
    Ahmed Y. Javed
    Awais Javed
    Fade A. Mahmoud
    Raymond U. Osarogiagbon
    Upender Manne
    BMC Cancer, 16
  • [45] A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer
    Govindarajan, Rangaswamy
    Posey, James
    Chao, Calvin Y.
    Lu, Ruixiao
    Jadhav, Trafina
    Javed, Ahmed Y.
    Javed, Awais
    Mahmoud, Fade A.
    Osarogiagbon, Raymond U.
    Manne, Upender
    BMC CANCER, 2016, 16
  • [46] Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
    Li, Kexuan
    Zhao, Fuqiang
    Guo, Yuchen
    Wu, Qingbin
    Luo, Shuangling
    Zhang, Junling
    Li, Heli
    Hu, Shidong
    Wu, Bin
    Lin, Guole
    Qiu, Huizhong
    Niu, Beizhan
    Sun, Xiyu
    Xu, Lai
    Lu, Junyang
    Du, Xiaohui
    Wang, Zheng
    Wang, Xin
    Kang, Liang
    Wang, Ziqiang
    Wang, Quan
    Liu, Qian
    Xiao, Yi
    BMC CANCER, 2023, 23 (01)
  • [47] BUDGET IMPACT OF ONCOTYPE DX GPS ASSAY IN PATIENTS WITH LOCALIZED PROSTATE CANCER IN GERMANY
    Tilki, D.
    Minartz, C.
    Herrmann, K.
    Kenny, K.
    Neubauer, A.
    VALUE IN HEALTH, 2020, 23 : S439 - S439
  • [48] Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
    Luca Licata
    Giulia Viale
    Mario Giuliano
    Giuseppe Curigliano
    Mariana Chavez-MacGregor
    Julia Foldi
    Oluchi Oke
    Joseph Collins
    Lucia Del Mastro
    Fabio Puglisi
    Filippo Montemurro
    Claudio Vernieri
    Lorenzo Gerratana
    Sara Giordano
    Alessia Rognone
    Lorenzo Sica
    Oreste Davide Gentilini
    Stefano Cascinu
    Lajos Pusztai
    Antonio Giordano
    Carmen Criscitiello
    Giampaolo Bianchini
    npj Breast Cancer, 9
  • [49] Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
    Licata, Luca
    Viale, Giulia
    Giuliano, Mario
    Curigliano, Giuseppe
    Chavez-MacGregor, Mariana
    Foldi, Julia
    Oke, Oluchi
    Collins, Joseph
    Del Mastro, Lucia
    Puglisi, Fabio
    Montemurro, Filippo
    Vernieri, Claudio
    Gerratana, Lorenzo
    Giordano, Sara
    Rognone, Alessia
    Sica, Lorenzo
    Gentilini, Oreste Davide
    Cascinu, Stefano
    Pusztai, Lajos
    Giordano, Antonio
    Criscitiello, Carmen
    Bianchini, Giampaolo
    NPJ BREAST CANCER, 2023, 9 (01)
  • [50] Risk Stratification in Patients with Stage II Colon Cancer
    Amri, Ramzi
    England, Jonathan
    Bordeianou, Liliana G.
    Berger, David L.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 3907 - 3914
12345